Search for: "Kyle"
Results 2581 - 2600
of 4,840
Sort by Relevance
|
Sort by Date
3 Sep 2015, 3:06 pm
Gene Quinn of IPWatchdog savaged the decision in the postWith dubious logic and inaccurate statements of law, PTAB denies another Kyle Bass IPR petitionThe decision is paper 23 of the case IPR2015-01136 .Bloomberg discussed the reaction of Kyle Bass:“They threw Acorda out on a technicality; they threw Biogen out by ignoring the law,” Bass said. [read post]
3 Sep 2015, 3:15 am
Carter, The Compellence Dilemma: International Disputes with Violent Groups Daniel Stevens, War and Elections Kyle Haynes, Decline and Devolution: The Sources of Strategic Military Retrenchment Kyle Beardsley, Kristian Skrede Gleditsch & Nigel Lo, Roving Bandits? [read post]
2 Sep 2015, 2:56 pm
The PTAB said that the full pilot study had not been made of record, which apparently also meant to the Board that the available description of the pilot study (described in the Kappos reference) was somehow not prior art. [read post]
2 Sep 2015, 2:56 pm
The post With dubious logic and inaccurate statements of law, PTAB denies another Kyle Bass IPR petition appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
2 Sep 2015, 6:54 am
Mowery; Pete Samborsky; Kyle Wade; Joseph Roda; Brook Wise; Gregory J. [read post]
31 Aug 2015, 7:17 pm
Kyle Jean-Baptiste was the youngest and the first African-American actor to play the role of Jean Valjean in the Broadway Musical “Les Miserables”. [read post]
31 Aug 2015, 2:21 pm
Syracuse, NY – Kyle Woodcock is hospitalized after his UPS tractor-trailer turned over in Syracuse on Saturday, August 29th, 2015. [read post]
31 Aug 2015, 7:21 am
Chris Versace (with a position at New Jersey City University (NJCU)) criticizes pharma industry proposals on IPRs, without mentioning the forays of Kyle Bass: According to a Politico report, “The drug industry is circulating a sign-on letter to build support for exempting drugs from a streamlined patent challenge process, a key issue stalling the House’s Innovation Act. [read post]
31 Aug 2015, 1:47 am
Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra disputeThe Coalition for Affordable Drugs (brain child of hedge-fund manager Kyle Bass) experiences disappointment as the USPTO opts not to review a couple of big-value pharma patents. [read post]
30 Aug 2015, 12:08 pm
” Kyle Graham found it and nominates North Carolina, Oregon, and Hawaii as states that currently follow their own path on common-law tort doctrine. [read post]
30 Aug 2015, 4:27 am
1, "Kyle Jean-Baptiste, the first African-American actor to play the iconic lead role of Jean Valjean in the popular Broadway musical 'Les Misérables,' died on Friday after falling from a fire escape in Brooklyn. [read post]
27 Aug 2015, 4:34 am
In Saline County, AR, the small community of Haskell is divided in their reactions to the arrest of 32-year-old Kyle Vaughan, who was arrested recently and fired from his job as a Haskell police officer, charged with sexual assault involving a juvenile, and child pornography. [read post]
26 Aug 2015, 6:34 pm
Wexler of Seyfarth Shaw on the firm’s blog, EEOC Year-End Countdown Kyle Bass Loses Round 1 Of IPR Attack Against Pharma/Biotech Patents – Linda X. [read post]
25 Aug 2015, 5:24 pm
”A petitioner may not appeal a decision not to institute an IPR proceeding (as happened in the Kyle Bass/Acorda matter over patent claims to the MS drug Ampyra). [read post]
25 Aug 2015, 12:14 pm
Kyle Barella is an immigration lawyer with his own firm. [read post]
25 Aug 2015, 12:07 pm
Further to an earlier IPBiz post, there has been discussion of PTAB's denial of Kyle Bass's petition on Acorda's Ampyra. [read post]
25 Aug 2015, 9:09 am
Acorda patents were challenged by the Coalition for Affordable Drugs, LLC, the entity formed by billionaire hedge fund manager Kyle Bass. [read post]
24 Aug 2015, 9:15 pm
The USPTO Patent Trial and Appeal Board (PTAB) has put an end to Kyle Bass’s Ampyra patent challenge, by denying institution of Inter Partes Review (IPR) proceedings. [read post]
24 Aug 2015, 5:37 pm
Susan Decker of Bloomberg wrote of Kyle Bass's loss at PTAB on Acorda/Ampyra:The U.S. [read post]
24 Aug 2015, 4:35 pm
Just as she was getting settled for some mindless television viewing after a long day, the AmeriKat received news that the USPTO's Patent Trial and Appeal Board (PTAB) has declined to institute two inter partes reviews (IPRs) filed by the Coalition for Affordable Drugs (the brain child of hedge-fund manager Kyle Bass - see AmeriKat post here). [read post]
